ireland, a winning proposial for research, development and innovation-ireland
Post on 30-May-2018
219 Views
Preview:
TRANSCRIPT
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
1/22
A WINNING PROPOSITION FOR
RESEARCH, DEVELOPMENT &
INNOVATION
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
2/22
CONTENTS01_ IRELAND - A PRIME LOCATION
FOR RD&I
02_ HOW IRELAND DELIVERS ON
ITS RD&I PROMISES
03_IRELANDS RD&I FRAMEWORK04_THE IRISH ADVANTAGE
P02
P04
P08P18
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
3/22
The Irish Government is ocused on driving economic growth by encouraging
urther RD&I activities. Its strategic objectives are backed with positive action through
an unprecedented investment o 8.2 billion under the Governments strategy or
Science Technology and Innovation. This unding is already building a world class
research system. The science strategy is also ensuring that all elements are working
in unison or the benet o industry. It is the Smart Economy made real.
Todays Ireland oers a strong, growing RD&I environment - complemented by a
robust Intellectual Property (IP) regime; a young skilled and well-educated workorce
with strong technological and business skills; and a low corporation tax.
The Drivers o Global RD&I
Access to the best talent, research and technology
Convergence between previously separate industries
The rate o continuous innovation required to keep pace with new business models
Research hotspots and networks that support and encourage RD&I
01_IRELAND A PRIME
LOCATION FOR RD&I
In every area o the contemporary business world,
progressive companies ace an ever-increasing demand to
innovate. This drive or advancement is one o the main
catalysts or the internationalisation o Research, Development
and Innovation (RD&I).
Ireland is now considered one o the leading RD&I locations in the
world. Ireland has the capacity to meet the needs o RD&I investors
and oers the ideal commercial, political and social environment
in which to carry out successul and protable RD&I activities.
02
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
4/22
IRELAND A WINNING PROPOSITION FOR RESEARCH, DEVELOPMENT AND INNOVATION
03
+_IRELAND: yOu ARE IN
GOOD COMPANy
What Ireland Oers
A pro-business environment with a 12.5% corporate tax rate
A long-established track record o working with multinational
corporations (MNCs)
Strong Intellectual Property protection
Well-established collaboration between a world-class academic
sector and industry
A highly-skilled workorce with strong managerial andcommunication abilities
Support and access to Government unding and RD&I networks
through IDA Ireland and Science Foundation Ireland
Excellent business inrastructure and Inormation and
Communications Technology (ICT)
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
5/22
Collaborative Research Environment
A unique eature o the Irish business environment is the
productive collaboration between industry, academia and
government agencies. All stakeholders work together,
building a national team to consolidate Irelands position
as a knowledge-based economy and as a primary locationor RD&I.
04
02_HOW IRELAND DELIVERS
ON ITS RD&I PROMISES
Irelands RD&I Landscape
ResearchCentres
GovernmentAgencies
Education/Third Level
GovernmentDepartments
Regulation
Industry
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
6/22
IRELAND A WINNING PROPOSITION FOR RESEARCH, DEVELOPMENT AND INNOVATION
05
IDA Ireland plays a leading role in RD&I development by providing
unding support to suitable projects, and by identiying other
supports available rom partner organisations such as Enterprise
Ireland, Science Foundation Ireland, and Sustainable Energy Ireland.
In addition to RD&I unding, IDA Ireland has a number o direct
support mechanisms, including employment and training grants.
Through its property portolio, IDA also has a suite o property
oerings or companies.
IDA Ireland works closely with companies to ensure they have the
acilities, resources and support they need to establish and expand
their RD&I operations. IDA helps ensure these progressive companies
continue to fourish here as key drivers o Irelands uture economic
success.
A Comprehensive Range o RD&I Programmes
IDA Irelands RD&I Programme, and Feasibility and
Training Support
Enterprise Irelands Innovation Partnerships Initiative
IDA Ireland/Enterprise Ireland Competence Centres
SFI Centres or Science, Engineering and Technology (CSET)
Programme EU 7th Framework Programme or Research and Technological
Development (FP7)
+_WORKING WITH yOu AND OTHERS
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
7/22
Centres for Science, Engineering and Technology (CSETs)
These centres are unded by Science Foundation Ireland and are ormed by clusters
o internationally competitive researchers rom the third-level sector and industry.
Their purpose is to exploit and develop opportunities in science engineering and
technology; in particular research that underpins developments in Biotechnology
ICT and Renewable Energy sectors.
A notable example is the Centre or Research on Adaptive Nanostructures &
Nanodevices (CRANN), located at Trinity College Dublin. The aim o CRANN is to
deliver world class research and innovation in nanoscience and nanotechnology
which will address key industry challenges. CRANN is a critical component o an
integrated national strategy to transition Ireland to a knowledge economy.
CRANNs industrial partners include Intel and H.P, with both companies having
researchers-in-residence in the CRANN acility.
RD&I Competence Centres
These are collaborative entities established and led by industry. They are resourced
by highly-qualifed researchers associated with research institutions who undertakemarket ocused strategic RD&I or the beneft o industry.
An RD&I Competence Centre is ormed when a group o companies come together
to defne their common research interest. The group then submits an expression
o interest to IDA Ireland or Enterprise Ireland outlining areas o common interest,
market presence and the strategic impact o a competence centre on their business
model. Expressions o interest that show highest potential impact will be selected to
progress or government unding. Participating companies must be open to working
with likeminded companies and prepared to collaborate with research perormers.Multinational companies that have participated to date include Medtronic, Intel,
Xilinx, Seagate, Analog Devices, DePuy and Bombardier Aerospace.
The National Institute for Biotechnology Research and Training (NIBRT)
NIBRT is an IDA-supported collaboration between our leading Irish academic
institutions. Its purpose is to deliver state-o-the-art training/learning acilities and
research solutions or the advancement o the BioPharma sector in Ireland.
+_ExamplEs of RD&I pRogRammEs
06
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
8/22
+_OTHER ELEMENTS INFLuENCING
RD&I IN IRELAND
Irish enterprise policy is ocused on creating
a smart economy or Ireland; an economy which
has at its core an exemplary research, innovation
and commercialisation ecosystem.
Key Elements o IDA Irelands RD&I Strategy
Leveraging recent investment by the Irish Government in RD&I
to support, develop and encourage multinational corporations
(MNCs) to undertake RD&I in Ireland
Fostering an environment o collaboration between government,
academia and MNCs
Ensuring RD&I policies are business riendly and attractiveto MNCs
Promoting Ireland as a location or carrying out world-class
RD&I
07IRELAND A WINNING PROPOSITION FOR RESEARCH, DEVELOPMENT AND INNOVATION
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
9/22
08
Ireland oers a world-class research development
and innovation (RD&I) model that delivers success or global
companies like AON, Intel, PayPal and Boston Scientic.
The ollowing sections explain how Ireland recognises the
optimum conditions needed or these companies to fourish
in the global RD&I environment.
03_IRELANDs RD&I FRAMEWORK
Key Elements of Irelands RD&I Success
A strong commitment and ocus by the Irish Government to RD&I
Irish legislation provides MNCs with incentives to generate qualiying
patents up to 5 million annual qualiying income can be exempt
rom Irish tax
R&D tax credit designed to encourage companies to undertake
new or additional R&D activity in Ireland. The tax credit covers wages,plant/machinery, buildings and related overheads o establishing an
RD&I activity in Ireland
A tax rate o 12.5% applies to all corporate trading prots
Clusters o global leaders in key high tech industries including
Pharmaceuticals, Medical Devices, Biotechnology, ICT and
Financial Services
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
10/22
IRELAND A WINNING PROPOSITION FOR RESEARCH, DEVELOPMENT AND INNOVATION
09
THE STANDALONEMODELIn this model, a company establishes a
dedicated centre to support either corporateresearch or an innovation agenda through
a standalone acility in Ireland.
THE COLLAbORATIVEMODELThe Collaborative Model describes an
RD&I investment that is co-dependent on a
substantial collaborative engagement with
an Irish or international academic institution
and/or with a MNC or indigenous Irish
company. You could call it a meeting o
minds and cross-discipline brainpower.
DEVELOPMENT &
MANuFACTuRING/SERVICE DELIVERyMODELThis reers to RD&I done at a
manuacturing or service delivery site
that improves the manuacturing or
service delivery process to achieve
greater productivity, eiciency and
quality o the operation or service.
THE DEVELOPMENT &
COMMERCIALISATIONMODELThe Development & Commercialisation
Model relates to instances o RD&I investments
where the outputs will be developed and
produced in Ireland or export markets.
+_FOuR MODELS FOR RD&I
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
11/22
Standalone Success in RD&I
Ireland has proven itsel a successul location or companies
wishing to establish standalone RD&I. As part o their
overall RD&I strategy and complimented by the skillsetso Irish researchers, a wide range o global companies have
successully managed to capture rst-mover advantage in
innovation, product development and design by setting up
RD&I Centres o Excellence in Ireland.
10
*THE STANDALONE
MODEL
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
12/22
CASE STuDIES
IRELAND A WINNING PROPOSITION FOR RESEARCH, DEVELOPMENT AND INNOVATION
11
CASE STuDIES
CiscoA worldwide leader in networking and collaboration products and services, Cisco
invested in a dedicated site or 250 research and development sta in Galway City.
From the outset, the Galway initiative has established a global leadership mandate in
Ciscos Unied Communications and Collaboration (UCC) portolio. Research conducted
here is at the very heart o Ciscos strategy in empowering The Human Network.
The project has established strong research partnerships and linkages with the
Science Foundation Ireland (SFI) unded CSET at the Digital Enterprise Research
Institute (DERI) in University College Galway, and with the Telecommunications
Sotware & Systems Group (TSSG) in Waterord Institute o Technology (WIT).
The Galway acility is also host to a European UCC customer brieng centre enabledby Ciscos TelePresence video technology.
AONIn nancial services, product and process innovation is now a core activity in driving
the strategic importance o the Irish operations. AON - providers o risk management
services, insurance and reinsurance brokerage - created an industry-rst when
choosing Dublin as the location or a Global Centre o Excellence. The Centre will
systematically aggregate inormation rom around the world using sophisticated
mathematical and analytical techniques, which Aon will translate into real-time
insights and innovative insurance products and risk solutions tailored to clients needs.This Centre o Excellence provides advanced research and development technology,
enabling the rm to drive product, process and business model innovation across
several disciplines.
HelsinnHelsinn, a privately owned pharmaceutical company, has established a Centre o
Excellence in Research and Development or Oral Solid Dosage (OSD) at its Dublin
acility, Helsinn Birex Pharmaceuticals. Helsinns core business is the in-licensing o
late stage pharmaceutical compounds in therapeutic niche areas or development
and subsequent commercial manuacture and distribution. The company is primarily
active in oncology supportive care, anti-infammatory and gastrointestinal treatments.
The investment is part o Helsinns strategic decision to strengthen its in-house
development capabilities. The Helsinn investment will establish the Irish operation
as the centre o knowledge and learning or OSD products in the Helsinn Group, and
the launch site or new products within its portolio. This investment puts the Irish
operation at the core o Helsinns R&D activities.
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
13/22
Irelands Collaborative Business Culture
Collaboration between industry and third level institutions
has become an important component o the Irish RD&I
landscape. More and more companies are orming industry/academic alliances to share costs and avail o the unique
skills available in research-perorming academic institutions
in Ireland.
12
*THE COLLAbORATIVE
MODEL
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
14/22
IRELAND A WINNING PROPOSITION FOR RESEARCH, DEVELOPMENT AND INNOVATION
13
CASE STuDIESCASE STuDIES
GlaxoSmithKlineGlaxoSmithKline (GSK) is one o the largest pharmaceutical companies in the world.
In its Irish RD&I operations, GSK is developing a ground-breaking research project
into gastrointestinal diseases, in collaboration with the Alimentary Pharmabiotic
Centre (APC) in University College Cork. This project is jointly supported by IDA Ireland
and Science Foundation Ireland (SFI). The company is also investing in a unique
collaboration with the Trinity College Institute o Neuroscience (TCIN) and the National
University o Ireland (NUI) Galway on a major Research & Development programme or
the discovery o new therapies to treat Alzheimers Disease.
IntelThe Irish campus is home to Intels IT Innovation Centre which is involved in ar-reaching research & development o applications including peer-to-peer networks,
digital health, mobility solutions, education deployment technologies (including
wireless & satellite) and e-learning architectures and platorms. The Irish operations
have responsibility or the direct management and governance o Intels innovation
labs across Europe. Intel also has an operation in Shannon, Co Clare designing
advanced microprocessors or use in embedded computing communications and
storage markets. Intel recently announced the expansion o this operation involving
industrial research in silicon design and validation and the development o a content
processor module. Intel is collaborating in this area with the Centre or Researchon Adaptive Nanostructures & Nanodevices (located at Trinity College Dublin),
the Tyndall National Institute in Cork and the National University o Ireland in
Maynooth.
Smith & NephewSmith & Nephew, the global medical technology company, and REMEDI, the
Regenerative Medicine Institute at NUI Galway, established a our year R&D
collaborative programme or the development o treatments or bone and joint
diseases. The Smith & Nephew Research Centre in York, United Kingdom, is working
in partnership with REMEDI to develop new therapies using adult bone marrow stem
cells to promote the re-growth o healthy cartilage and the repair o damaged joints.
REMEDI, recognised as Irelands primary centre or stem cell and gene therapy
research, was established as a Centre or Science, Engineering and Technology
(CSET ) in 2004 by Science Foundation Ireland. It has a core expertise in arthritis
research and a particular emphasis on the translation o its research ndings to
the delivery o new therapies in orthopaedics, cardiovascular and neural diseases.
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
15/22
The Development and Manuacturing/Service Delivery
Model reers to RD&I carried out at a manuacturing or
service delivery site that improves the manuacturing or
service delivery process to achieve greater productivity,eciency and quality o the operation.
14
*DEVELOPMENT &
MANuFACTuRING/SERVICE
DELIVERy MODEL
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
16/22
Stryker InstrumentsStryker Instruments, part o the Stryker Corporation, is known or a wide range
o innovative operating room products - rom surgical power tools to advanced
systems or waste management, irrigation, personal protection and pain management.
Established in 1998, Strykers Cork plant has successully developed a state-o-the-art
research and development and manuacturing acility or minimally invasive surgical
instruments. These products are used or cutting, drilling, burring and shaping o
bone and sot tissue during orthopaedic, spine, ear, nose and throat plastic surgery.
The R&D team in Cork is involved in both product and process development with
sole responsibility or the development, pilot manuacturing, regulatory approval
and commercial manuacture o disposable bone and sot tissue cutting instruments.
MerckMerck established its rst Irish operation in Co. Tipperary in 1976. The construction
o a new 200,000 sq t acility in Ireland when complete, will enable all the unit
processes to manuacture nal stage (Phase III) clinical trial solid dosage (tablets &
capsules) or global clinical trials. The acility will be used to manuacture, market
and launch quantities o newly approved drugs prior to their manuacture in long term
supply sites. Signicant parts o this operation will have a large R&D element involved
in new process development including Process Analytical Technology and in-process
measurement systems, tablet & capsule ormulation development, and thedevelopment o new analytical methods or each new medicine.
PaypalPaypal, an eBay company, set up their European Operations Centre (EOC) in Dublin
in 2003, serving markets in Italy, France, Germany, Spain, UK, Netherlands and Poland.
Paypal Ireland now employs some 900 ulltime sta across it portolio o activities
such as European Customer Services, Risk & Fraud Management and Merchant
Solutions. The company recently initiated a Customer Centre o Excellence which
will see the EOC evolve into an operation with responsibility or developing Customer
Service and Operational Excellence within the PayPal Group. The Centre o Excellence
will be involved in re-engineering the end-to-end customer experience working
across European operations and with the companys European Business Units to
dene and implement innovative solutions in product, process, policy and technology;
a signicant upward move in relation to value added activities. PayPals Centre o
Excellence will be working with the Innovation Value Institute in the National
University o Ireland at Maynooth.
CASE STuDIESCASE STuDIES
IRELAND A WINNING PROPOSITION FOR RESEARCH, DEVELOPMENT AND INNOVATION
15
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
17/22
16
Commercialisation is the successul implementation o a novel
idea into something o value to the marketplace. The successul
commercialisation o new products or services in Ireland can
lead to increased revenue, market share, and protability.Ireland has a strong track record o companies developing and
delivering new products and services to the market across a
wide sectoral range.
*THE DEVELOPMENT AND
COMMERCIALISATION
MODEL
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
18/22
AnalogThe ocus o Analogs Irish operation is to produce quality precision products through
precision manuacturing, while exploiting cost-eciencies. Innovation is ostered
through teamwork, both within the Irish operation and through cross-national
research teams throughout Analog Devices globally. The company has recently
upgraded its waer manuacturing acility in Limerick moving rom a 6 ab to an
8 ab. The Limerick based R&D team o over 400 engineers are involved in IC layout,
Analog design (custom transistor level design), Digital/ASIC design, system design,
product/test engineering and semiconductor process technology. Access to R&D and
highly skilled manuacturing and technological experts allows the Ireland operation
develop an average o 80 new products each year. The Irish R&D team has soleresponsibility within Analog or the global design, manuacture and supply o value
added high voltage mixed signal CMOS products.
Boston ScientifcBoston Scientic specialises in manuacturing medical devices or use in minimally
invasive surgical procedures. The company set up its rst operation in Ireland in
1994, in Galway. The Galway acility is the companys largest operation in Ireland,
manuacturing cardiology related products stents, catheters and guidewires.
This operation also has one o the largest R&D teams in Ireland. Boston Scientic
has recently announced an RD&I investment at its Cork acility refecting theenhanced capability o this acility or the development and commercialisation o
next generation products to treat neurovascular diseases o the brain, including coils,
intracranial stent delivery systems and access devices. Boston Scientic Corporation
currently employs 5,000 people in Ireland.
MedtronicMedtronic has been present in Ireland since 1999. Medtronics Galway site is a Centre
o Excellence or the development and manuacture o key medical technologies in
the treatment and management o cardiovascular and cardiac rhythm diseases,
employing over 2000 people in Ireland working at state-o-the-art acilities in Galway.
This gure includes over 90 Research & Development personnel working on a number
o high value projects such as the development o next generation cardiovascular
products and Cardiac Rhythm Disease Management delivery systems. A large
proportion o the products manuactured at Medtronics Galway site result rom R&D
carried out at the acility. The company also maintains R&D links with many third
level institutions throughout Ireland as the countrys academic climate gives
it access to highly-trained medical technology research and development experts.
CASE STuDIESCASE STuDIES
IRELAND A WINNING PROPOSITION FOR RESEARCH, DEVELOPMENT AND INNOVATION
17
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
19/22
18
Ireland is a proven location or RD&I with a successul
track record across multiple industry sectors, based on the
unique combination o benets on oer to global business:
A stable political environment and respected regulatory regime A pro-business environment with a 12.5% corporate tax rate, tax credits
or RD&I activities and an extensive double tax treaty network with
51 countries
A high-skills, knowledge-based economy delivering quality, highly
productive employees with excellent technical, managerial and
multilingual customer service skills
A reputation or fexibility, responsiveness and innovation
Forty years experience working with MNCs to establish andexpand operations across a wide range o sectors
Clusters o global leaders in key high tech industries including
pharmaceuticals, medical devices and ICT
Experienced and innovative leaders ocused on proactively
identiying and solving business challenges
Strong Government support or RD&I ocused on highly
productive alliances between industry and academia
Excellent legal expertise or the commercialisation andprotection o intellectual property rights
04_THE IRISH ADVANTAGE
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
20/22
19IRELAND A WINNING PROPOSITION FOR RESEARCH, DEVELOPMENT AND INNOVATION
+_CONTACT IDA IRELAND
IDA Ireland oers inormation, advice and ongoing support
to companies setting up or expanding RD&I operations in Ireland.
IDA Ireland is Irelands inward investment promotion agency.
The agency works with companies to secure new investment
and collaborates with existing oreign investors in Ireland to
help expand and develop their businesses. To learn more log
on to www.idaireland.comor contact any IDA oce.
HeadquartersIDA Ireland, Wilton Place,Dublin 2, Ireland.Tel: +353 1 603 4000Fax: +353 1 603 4040e-mail: idaireland@ida.ieweb:www.idaireland.com
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
21/22
20
+_IDA GLObAL OFFICE NETWORK
IRELAND
India501, 5th Floor,Blue Wave Building,B/h Kuber Complex,O Oshiwara Link Road,
Andheri (West),Mumbai-400 053Tel: +91-22-42178900Fax:+91-22-42178999
JapanIreland House 2F2-10-7 KojimachiChiyoda-KuTokyo 102-0083Tel: +81 3 3262 7621Fax: +813 3261 4239
Korea13th Floor Leema B/D
146-1 Susong-dong, Jongro-kuSeoul 110-755Tel: +82 2 755 4767/8Fax: +82 2 757 3969
Taiwan7FL-12, No.41Nanking W. RoadTaipei 103TaiwanTel: +886 2 2552 6101Fax: +8862 2550 7220
AthloneAthlone Business &Technology ParkGarrycastle, Dublin Rd.
AthloneWestmeathTel: +353 (0) 90 64 71500Fax: +353 (0) 90 64 71550
CavanIDA Business ParkDublin RoadCavanTel: +353 (0) 49 436 8820Fax: +353 (0) 49 433 2047
CorkIndustry HouseRossa Avenue
BishopstownCorkTel: +353 (0) 21 480 0210Fax: +353 (0) 21 480 0202
DonegalPortland HousePort Road, LetterkennyDonegalTel: +353 (0) 74 916 9810Fax: +353 (0) 74 916 9801
DundalkFinnabair Business ParkDundalkLouthTel: +353 (0) 42 935 4410Fax: +353 (0) 42 935 4411
GalwayMervue Business ParkGalwayTel: +353 (0) 91 735 910Fax: +353 (0) 91 735 911
LimerickRoselawn HouseNational Technology ParkLimerickTel: +353 (0) 61 200 513Fax: +353 (0) 61 200 399
SligoFinisklin Business ParkSligoTel: +353 (0) 71 915 9710Fax: +353 (0) 71 915 9711
Waterord
Waterord Technology ParkCork RoadWaterordTel: +353 (0) 51 333 055Fax: +353 (0) 51 333 054
FranceMaison dIrlande33 rue de Miromesnil75008 ParisTel: +33 (0) 1 43 12 91 80Fax: +33 (0) 1 47 42 84 76
GermanyFBC Frankurter Bro CenterMainzer Landstr. 4660325 Frankurt am MainTel: +49 (0) 69 706099-0Fax: +49 (0) 69 706099-70
AtlantaMonarch Plaza,Suite 3503414 Peachtree Road,N.E., Atlanta,GA 30326Tel: +1 404 816 7096Fax:+1 404 846 0728
Boston31 Saint James Avenue,7th Floor, Boston,MA 02116.Tel: +1 617 357 4190Fax:+1 617 357 4198
Caliornia3 Park Plaza,Suite 430,Irvine, CA 92614.Tel: +1 949 748 3547Fax:+1 949 748 3586
800 W. El Camino RealSuite 450,Mountain View, CA 94040Tel: +1 650 967 9903Fax:+1 650 967 9904
RussiaEmbassy o IrelandGrokholski Pereulok 5Moscow 129010Tel: +7 495 937 5911Fax: +7 495 680 0623
United KingdomShatesbury House151 Shatesbury AvenueLondon WC2H 8ALTel: +44 (0) 20 7379 9728Fax: +44 (0) 20 7395 7599
BrazilAv. das Naes Unidas,12551 - 17 andar04578-903 S. Paulo - SPBrazilTel: +55 11 3443 7080Fax:+55 11 4992 0406
AustraliaIreland HouseSuite 2601, Level 261 Market StreetSydney NSW 2000Tel: +61 (0)2 9273 8524Fax:+61(0)2 9273 8527
ChinaSuite 655Shanghai Centre1376 Nanjing Road WestShanghai 200040Tel: +86 21 6279 8500Fax:+86 21 6279 8505
EUROPE
USA
SOUTH AMERICA
ASIA-PACIFIC
Chicago77 West Wacker DriveSuite 4070Chicago, IL 60601-1629Tel: +1 312 236 0222Fax: +1 312 236 3407
New York345 Park Avenue, 17th FloorNew York, NY 10154-0004Tel: +1 212 750 4300Fax: +1 212 750 7357
-
8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland
22/22
WWW.IDAIRELAND.COM
DESIG
NBYCREATIVEINC
top related